3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
CNS
1
Conditions
Brain Neoplasms
4
Neoplasms
2
Breast Neoplasms
2
Sarcoma
1
Prostatic Neoplasms
1
Pituitary Neoplasms
1
Osteosarcoma
1
Oligodendroglioma
1
Neurotoxicity Syndromes
1
Neurofibromatosis 1
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Meningioma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Hodgkin Disease
1
Glioma
1
Glioblastoma
1
Fatigue
1
Cytokine Release Syndrome
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Astrocytoma
1
Interventions
pasireotide
7
Cabergoline
7
Temozolomide
3
Propofol
3
Hydrocortisone
3
Dexmedetomidine
3
lanreotide
2
Sevoflurane
2
Saline Solution
2
Rosiglitazone
2
Proton Therapy
2
Octreotide
2
Dexamethasone
2
Desflurane
2
pegvisomant
1
parecoxib
1
lutetium Lu 177 dotatate
1
loxoprofen
1
farletuzumab
1
entinostat
1
corticorelin ovine
1
antineoplaston AS 2-1
1
antineoplaston A10
1
Yoga
1
Trimethoprim
1
Transcranial Magnetic Stimulation
1
Tranexamic Acid
1
Tramadol
1
Thyrotropin-Releasing Hormone
1
TBR-760
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Pituitary Neoplasms
×
Neuropsychological Tests
×
Clear all
NCT05727605
2024-05-08
NARCiS
Universitaire Ziekenhuizen KU Leuven
Phase NA
Recruiting
120 enrolled